# Acceptance and Commitment Therapy (ACT) - Based Treatment Development for Cancer Patients Treated for Pain

> **NCT03910296** · — · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 10 (actual)

## Conditions studied

- Cancer

## Interventions

- **BEHAVIORAL:** Acceptance & Commitment Therapy

## Key facts

- **NCT ID:** NCT03910296
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-20
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-07-30
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03910296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03910296, "Acceptance and Commitment Therapy (ACT) - Based Treatment Development for Cancer Patients Treated for Pain". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03910296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*